MAPT and Alzheimer disease: We then investigated the association of the slopes of MTL and PMC FC strength and subsequent AD pathology (i.e. Aβ- and tau-PET burden) using linear models including the interaction of FC slope by APOE4 group, age, sex, education, and time between baseline session and PET.